←Back to Expert Scholars
Translational Medicine / 转化医学Pancreatic Cancer Systemic Therapy
Eileen M. O'Reilly
MD
🏢Memorial Sloan Kettering Cancer Center🌐USA
Section Head, Hepatopancreatobiliary Oncology
85
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Dr. Eileen O'Reilly leads hepatopancreatobiliary oncology at Memorial Sloan Kettering. She has led pivotal pancreatic cancer trials including studies of olaparib in BRCA mutated disease. Her work shapes international guidelines for systemic pancreatic cancer management.
Share:
🧪Research Fields 研究领域
pancreatic adenocarcinoma
FOLFIRINOX
clinical trials
BRCA
PARP inhibitors
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Eileen M. O'Reilly 的研究动态
Follow Eileen M. O'Reilly's research updates
留下邮箱，当我们发布与 Eileen M. O'Reilly（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment